Basit öğe kaydını göster

dc.contributor.authorKalemci, Serdar
dc.contributor.authorTopal, Yasar
dc.contributor.authorCelik, Serkan Yasar
dc.contributor.authorYilmaz, Nigar
dc.contributor.authorBeydilli, Halil
dc.contributor.authorKosar, Mehmet Ilkay
dc.contributor.authorAltuntas, Irfan
dc.date.accessioned2020-11-20T15:05:09Z
dc.date.available2020-11-20T15:05:09Z
dc.date.issued2015
dc.identifier.issn1792-0981
dc.identifier.issn1792-1015
dc.identifier.urihttps://doi.org/10.3892/etm.2015.2542
dc.identifier.urihttps://hdl.handle.net/20.500.12809/2977
dc.descriptionWOS: 000358679400018en_US
dc.descriptionPubMed ID: 26622344en_US
dc.description.abstractThe aim of the present study was to assess the protective effect of silibinin against methotrexate (MTX)-induced pulmonary toxicity. Rats were divided into four groups (MTX, MTX + silibinin, silibinin and control. MTX was injected intraperitoneally (i.p) into female Wistar rats (10 mg/kg/day for 3 days), which resulted in significant increases in the serum levels of alanine aminotransferase, aspartate aminotransferase and oxidant enzymes, including nitric oxide and myeloperoxidase. Furthermore, significant reductions were detected in the serum activity levels of the antioxidative enzymes, glutathione peroxidase and superoxide dismutase, when compared with the control group. However, administration of silibinin (100 mg/kg/day for 10 days, i.p.) was shown to ameliorate the MTX-induced pulmonary toxicity, as indicated by the normalization of the oxidative stress parameters. Furthermore, silibinin treatment was demonstrated to reduce the histopathological changes associated with MTX. In conclusion, silibinin exhibited protective effects against MTX-induced pulmonary toxicity, which may be attributed to its antioxidant activity.en_US
dc.item-language.isoengen_US
dc.publisherSpandidos Publ Ltden_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMethotrexateen_US
dc.subjectSilibininen_US
dc.subjectPulmonary Toxicityen_US
dc.subjectAntioxidanten_US
dc.subjectRaten_US
dc.titleSilibinin attenuates methotrexate-induced pulmonary injury by targeting oxidative stressen_US
dc.item-typearticleen_US
dc.contributor.departmenten_US
dc.contributor.departmentTemp[Kalemci, Serdar] Mugla Sitki Kocman Univ, Fac Med, Dept Chest Dis, TR-48000 Mugla, Turkey -- [Topal, Yasar] Mugla Sitki Kocman Univ, Fac Med, Dept Pediat, TR-48000 Mugla, Turkey -- [Celik, Serkan Yasar] Mugla Sitki Kocman Univ, Fac Med, Dept Pathol, TR-48000 Mugla, Turkey -- [Yilmaz, Nigar; Altuntas, Irfan] Mugla Sitki Kocman Univ, Fac Med, Dept Biochem, TR-48000 Mugla, Turkey -- [Beydilli, Halil] Mugla Sitki Kocman Univ, Fac Med, Dept Emergency Med, TR-48000 Mugla, Turkey -- [Kosar, Mehmet Ilkay] Mugla Sitki Kocman Univ, Fac Med, Dept Anat, TR-48000 Mugla, Turkeyen_US
dc.identifier.doi10.3892/etm.2015.2542
dc.identifier.volume10en_US
dc.identifier.issue2en_US
dc.identifier.startpage503en_US
dc.identifier.endpage507en_US
dc.relation.journalExperimental and Therapeutic Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster